Email: cspc@cspc.cn

Contact Us
EN

News

News

Home > Media > News > VOLUNTARY ANNOUNCEMENT - GOSERELIN SUSTAINED-RELEASE INJECTION (SYH9102 INJECTION) OBTAINS CLINICAL TRIAL APPROVAL IN CHINA

VOLUNTARY ANNOUNCEMENT - GOSERELIN SUSTAINED-RELEASE INJECTION (SYH9102 INJECTION) OBTAINS CLINICAL TRIAL APPROVAL IN CHINA

September 09, 2026

a260909_00.png

Previous: VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL TRIAL OF SYH2069 INJECTION FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN ADULT PATIENTS OFFICIALLY INITIATED AT TH

Next: VOLUNTARY ANNOUNCEMENT - PHASE I CLINICAL TRIAL OF SYS6063 FOR THE TREATMENT OF RELAPSED, REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS OFFICIALLY INITIATED AT THE FI

Contact Us

Phone:

+86 311 8703 7015

Email:

cspc@cspc.cn

Products

Science

About Us

Legal terms Privacy protection
Copyright © CSPC PHARMACEUTICAL GROUP LIMITED All Rights Reserved | 冀ICP备05003393号

Wechat